| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.327 | 21.171 | 22.259 | 19.701 | 18.767 | 27.796 | 22.833 | 17.862 | 16.952 | 15.245 |
| Total Income - EUR | 25.394 | 21.171 | 22.259 | 19.723 | 20.559 | 27.796 | 22.833 | 17.862 | 16.952 | 15.245 |
| Total Expenses - EUR | 21.382 | 18.974 | 19.606 | 19.043 | 18.596 | 24.571 | 21.217 | 16.961 | 17.320 | 14.727 |
| Gross Profit/Loss - EUR | 4.011 | 2.197 | 2.653 | 680 | 1.963 | 3.224 | 1.616 | 901 | -367 | 518 |
| Net Profit/Loss - EUR | 3.250 | 1.554 | 1.981 | 98 | 1.338 | 2.446 | 992 | 418 | -367 | 430 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Emafarm Si Vet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.965 | 1.192 | 432 | 0 | 551 | 360 | 176 | 0 | 0 | 0 |
| Current Assets | 20.704 | 20.369 | 22.342 | 21.758 | 22.109 | 24.440 | 24.881 | 25.540 | 21.065 | 17.183 |
| Inventories | 4.615 | 4.921 | 5.156 | 4.779 | 5.545 | 6.405 | 7.119 | 6.736 | 4.838 | 4.429 |
| Receivables | 15.933 | 13.487 | 16.640 | 15.678 | 15.480 | 14.543 | 14.204 | 14.280 | 10.658 | 6.519 |
| Cash | 156 | 1.962 | 547 | 1.300 | 1.085 | 3.492 | 3.559 | 4.524 | 5.569 | 6.235 |
| Shareholders Funds | 18.871 | 20.232 | 21.871 | 21.568 | 22.488 | 24.508 | 24.957 | 25.452 | 21.065 | 17.051 |
| Social Capital | 45 | 44 | 43 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.798 | 1.329 | 903 | 190 | 172 | 293 | 101 | 88 | 0 | 131 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Emafarm Si Vet S.r.l.